Biochemical and Biophysical Research Communications
GCN2 suppression attenuates cerebral ischemia in mice by reducing apoptosis and endoplasmic reticulum (ER) stress through the blockage of FoxO3a-regulated ROS production
Introduction
Ischemic stroke is one of the leading causes of morbidity and mortality worldwide [1]. Despite rapid reperfusion is a significant therapeutic strategy for ischemic stroke. It can paradoxically result in elevated cerebral ischemia and reperfusion (IR) injury [2]. The molecular mechanisms of IR injury include multiple pathophysiological processes, such as abnormal apoptosis, oxidative stress and endoplasmic reticulum stress (ERS) [3,4]. As the importance of cerebral ischemic stroke is becoming increasingly evident, it is critical to develop new therapies to prevent cerebral injury.
General control nonderepressible 2 (GCN2) was first reported as a sensor of amino acid availability in yeast [5]. Under conditions of amino acid deprivation, GCN2 could phosphorylate eukaryotic initiation factor 2 alpha (eIF2α) to increase amino acid biosynthesis, and this process was tightly associated with the progression of ERS [6]. GCN2 elevates myocardial oxidative stress under stress conditions by promoting its down-streaming signals [7]. GCN2 ablation ameliorated transverse aortic constriction (TAC)-induced cardiac dysfunction associated with the inhibition of cardiomyocyte apoptosis [8]. GCN2 knockout protects against high-fat diet (HFD)-induced hepatic steatosis and insulin resistance [9]. Additionally, GCN2 deficiency was involved in the improvement of hippocampal synaptic plasticity and memory [10]. Thus, we hypothesized GCN2 inhibition might be implicated in the development of cerebral ischemia. However, if reducing GCN2 expression with its inhibitor GCN2iB can alleviate cerebral I/R injury and its possible mechanism remains unknown.
In this study, we explored if GCN2 suppression could regulate MCAO-induced cerebral I/R injury. We also investigated the potential molecular mechanisms implicated in the effects of GCN2 suppression on apoptosis, oxidative stress and ERS.
Section snippets
Experimental animals
The adult, male C57BL/6 mice (20–25 g) were obtained from the Laboratory Animal Center of the Shandong University (Shandong, China). All procedures and ethics guidelines were approved by the Committee for Experimental Animal Use and Care of the Shandong Provincial Hospital Affiliated To Shandong University, China. Efforts here were made to minimize the number of animals used and their suffering. The AAV9 vectors carrying GCN2 (AAV-GCN2) were constructed by GeneChem Co., Ltd. (Shanghai, China).
GCN2 expression was up-regulated after cerebral ischemia and GCN2iB treatment alleviated cerebral ischemia in mice following I/R-induced ischemic brain damage
Focal ischemia induced by MCAO led to increased brain damage with reperfusion time (12, 24, 48 or 72 h) following I/R, along with significantly up-regulated infarction area (Fig. 1A). RT-qPCR and western blot analysis indicated that GCN2 mRNA and protein levels in ischemic penumbra were markedly increased at different time points following I/R (Fig. 1B and C). Besides, OGD/R led to the increase of GCN2 in N2a cells as MCAO mice at different time points of reoxygenation (Fig. 1D and E). These
Discussion
In this study, we attempted to explore if targeting GCN2 could alleviate cerebral I/R injury and the underlying molecular mechanisms that controlled this process. The effect of GCN2 was first calculated using a classical animal model of I/R by MCAO operation. GCN2 over-expression markedly promoted the infarct size. However, GCN2 suppression alleviated MCAO-induced oxidative stress, apoptotic and ERS protein expression in vivo to improve cerebral ischemic injury. At the same time,
Acknowledgement
National Natural Science Foundation of China (81660210); The Key Research and Development Foundation of Shaanxi Province, China (2016SF-173, 2018SF-107); Science and Technology Project of Xi'an, Shaanxi Province, China (2017114SF/YX008(3)).
References (31)
KCa3. 1 inhibition switches the astrocyte phenotype during astrogliosis associated with ischemic stroke via endoplasmic reticulum stress and MAPK signaling pathways
Front. Cell. Neurosci.
(2017)GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress
Redox Biol
(2018)GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice
BBA-Mol Basis Dis.
(2018)Immunohistochemical investigation of the internal structure of the mouse subiculum
Neuroscience
(2016)Axl activation attenuates neuroinflammation by inhibiting the TLR/TRAF/NF-κB pathway after MCAO in rats
Neurobiol. Dis.
(2018)Role of Nox4 in murine models of kidney disease
Free Radic. Biol. Med.
(2012)Ischemic postconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PI3K-Akt pathway
Brain Res.
(2011)Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats
Eur. J. Pharm. Sci.
(2011)Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-κB pathways and inhibition of intracellular ROS/RNS generation
Free Radic. Biol. Med.
(2009)AMPK activates FOXO3a and promotes neuronal apoptosis in the developing rat brain during the early phase after hypoxia-ischemia
Brain Res. Bull.
(2017)